JOHN B. BUSE

Metformin at the Time of COVID‐19 Infection and Risk of Long COVID: A Target Trial Emulation Study

ABSTRACT Our objective was to evaluate metformin prescribed at the time of SARS‐CoV‐2 infection on the risk of developing Long COVID (LC) in electronic health record data. We conducted a new user analysis of metformin prescribed within 6 days of documented infection with severe a...